Editas Medicine (EDIT) Non-Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Non-Current Assets data on file, last reported at $22.6 million in Q4 2025.

• Non-Current Assets for Q4 2025 came in at $22.6 million, down 56.69% year-over-year; the trailing twelve-month figure through Dec 2025 was $114.1 million (down 66.63% YoY), and the FY2025 annual result was $22.6 million, down 56.69% from the prior year.
• Non-Current Assets fell to $22.6 million in Q4 2025 per EDIT's latest filing, from $24.9 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $170.2 million in Q4 2021 and troughed at $22.6 million in Q4 2025.
• A 5-year average of $105.8 million and a median of $122.8 million in 2022 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2021 and 2025: Non-Current Assets jumped 255.45% in 2021, then sank 71.78% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $170.2 million in 2021, then decreased by 7.41% to $157.6 million in 2022, then increased by 0.48% to $158.3 million in 2023, then slumped by 66.98% to $52.3 million in 2024, then plunged by 56.69% to $22.6 million in 2025.
• Business Quant data shows EDIT's Non-Current Assets at $22.6 million in Q4 2025, $24.9 million in Q3 2025, and $27.8 million in Q2 2025.